Seminar
Descriptions |
|
| Scroll down to view seminar descriptions
and speakers, or click on the accompany "Details" button
for more information on the topic. |
|
| SPONSOR |
SPONSOR |
SPONSOR |
SPONSOR |
SPONSOR |
SPONSOR |
SPONSOR |
 |
 |
|
 |
 |
|
 |
| Therapeutics |
Diagnostics |
Health
IT |
Market
Development |
Finance |
International |
Talent
& Management |
|
| Session
1 | 10:15 - 11:45 a.m. |
| Medical
Devices Needed for Regenerative Medicine |
 |
|
| Predictive & Personalized
Diagnostics |
|
|
| There’s
an App for That* |
|
|
| Global
Growth Markets for New Therapies |
|
|
| Strategic
Growth in the New World Economy |
|
|
| Regulatory
Affairs in a Flat World |
|
|
| Managing
Tomorrow’s Workforce |
|
|
|
| Session
2 | 2:00
- 3:30 p.m. |
| Innovative
Collaborations in Product Development |
|
|
| Reimbursement & Market
Adoption of Diagnostic Platforms |
|
|
| Effectively
Harnessing the Deluge of Data |
|
|
| Using
Social Media and Direct-to-Consumer Marketing
in a Regulated Environment |
|
|
| Navigating
the Valley of Death — Accessing Capital
from Diverse Sources |
|
|
| Care
Goes Global |
|
|
| Game
Changers of the Future — The New Class
of Innovators |
|
|
|
| |
| |
| Session
1 | 10:15
- 11:45 a.m. |
Therapeutics
Session 1:
Medical Devices Needed for Regenerative Medicine |
Experts
in the field of cardiology, neurology and
orthopedics will discuss current and future
applications of regenerative medicine. In
addition, they will address the challenges
of delivering stem cells and tissues with
examples of how the device industry plays
a critical role in combination products.
Beyond the science and engineering, they'll
consider regulatory and reimbursement issues
facing these therapies as well as the challenges
of getting them to market.
|
|
Diagnostics
Session 1:
Predictive & Personalized Diagnostics |
As
medicine moves closer to a predictive,
preventive and personalized model,
gene-based diagnostics, biomarkers and
algorithms are being used to help identify
which patients are likely to benefit
most from a given therapy, whether it
is a medical device, biologic or pharmaceutical. Learn
what's on the horizon in predictive tools
and how they will affect the development
and sales of devices, drugs & other
therapies.
|
|
Health
IT
Session 1:
There’s an App
for That* |
Mobile
health applications are rapidly changing
how care is delivered. In this session,
you'll hear from companies who have developed
exciting new patient-centered applications
and those who interface on both the health
care and wellness side. You'll also hear
predictions for the future of mobile health
applications, get a sense of how these
tools are likely to fit within HIPAA and
gain an understanding of what it takes
to bring a new app to market.
*”There’s
an App for that” is a trademark of Apple,
Inc. |
|
Market
Development
Session 1:
Global Growth Markets for New Therapies
|
International
marketing is not just the domain of global
giants. Emerging life science companies
can expand their markets abroad with the
right approaches and networks. Experienced
international market specialists will share
insights on the hot countries for new products
and will address the challenges in establishing
an OUS distribution system.
|
|
Finance
Session
1:
Strategic Growth in the New World Economy
|
Established
as well as mid-size and emerging companies
need to understand what future growth
will look like through strategic partnerships,
licensing deals, mergers and acquisitions
and investments around the globe. Gain
insights from industry players and advisors
who have successfully implemented investment
strategies in countries such as India,
Brazil and Japan. Learn what
it takes to navigate challenging government,
cultural and marketplace barriers.
|
|
International
Session
1:
Regulatory Affairs
in a Flat World
|
Given
the increasing regulatory barriers in
the U.S., what countries are emerging
as effective sites for clinical trials
and regulatory approval? How are
changing OUS regulatory structures affecting
your regulatory pathway? This session
will consider the risks and benefits
of regulatory environments in less well
known regions, such as China, India and
South America, and address the prospects
for successful FDA data submissions.
|
|
Talent
& Management
Session 1:
Managing Tomorrow’s Workforce
|
Tomorrow’s
leaders must adapt to managing a virtual and
multi-generational workforce, keeping their
teams connected to both the needs of their
industry and the missions of their organizations.
How can you support the transfer of knowledge
and maintain your leadership in this New World
business model? Learn how to maximize
the benefits and work around the obstacles
when managing the team of the future.
|
|
| |
| Session
2 | 2:00
- 3:30 p.m. |
Therapeutics
Session 2:
Innovative Collaborations in Product Development |
This
session will explore the value of partnerships
in new drug and device product development. Fast-tracked
and virtual companies rely on partnerships
with design and manufacturing firms, university-industry
relationships, strategic alliances between
large and small companies and collaborations
between physicians and engineers — all
aimed at adding greater value to the patient
and other stakeholders in the health ecosystem.
What will the partnerships of the future
look like? |
|
Diagnostics
Session
2:
Reimbursement & Market
Adoption of Diagnostic Platforms
|
With
health care spending on the rise, the
need for game-changing technologies that
deliver quality care and radically lower
costs has never been greater. This
is where diagnostic platforms make a
compelling case, integrating biomarkers,
sensors, microfluidics, software, hardware,
bioinformatics and more. Who will
drive the adoption and reimbursement
of these tools? What are the implications
for your product and market development?
|
|
Health
IT
Session 2:
Effectively Harnessing the Deluge of Data |
One
of the most pressing issues of our time
is the explosion of health information
and the need for integration. What can
manufacturers, clinical decision-makers,
health plans and patients learn from bioinformatics
and health records data? What value can
be derived in a comparative effectiveness
research context? How can cloud computing
and storage be done securely? This session
will also explore what new companies and
careers are likely to form around this
emerging industry.
|
|
Market
Development
Session 2:
Using Social Media and Direct-to-Consumer Marketing in a Regulated Environment
|
Beyond
Facebook, LinkedIn and Twitter, social
media plays an increasingly important role
in the life sciences. It's critical to
understand both the opportunities as well
as potential barriers in marketing your
products and services to purchasers and
end-users. How will the FDA weigh in on
industry's use of social media? What are
likely to emerge as best practices in this
domain?
|
|
Finance
Session 2:
Navigating the Valley of Death
— Accessing Capital from Diverse Sources
|
The
funding landscape for life science start-ups
is changing dramatically in these capital-scarce
times. In this session, the audience
will engage with a diverse group of funders
to identify various traditional and non-traditional
investment sources to bridge the Valley
of Death funding gap. Discussion will focus
on what value proposition is likely to
attract various forms of early stage investment
and what money is available, where.
|
|
International
Session 2:
Care Goes Global
|
Medical
Tourism is revolutionizing health care
in developed nations such as the U.S.,
with more patients going abroad,or even
traveling to domestic centers of excellence,
in search of expertise and value. This
session will open your eyes to "hot
spots" around the globe that are already
creating competition for local health care
providers, while potentially opening up
new markets for medical products. What
are the implications of this growing trend?
|
|
Talent
& Management
Session 2:
Game Changers of the Future
— The New Class of Innovators
|
Large
companies may have the budgets, but do
they have the fertile cultures needed
to discover and incubate the next breakthroughs? Where
does your expertise reside internally
and how do you gather it for optimal
results? What value do smaller
companies, entrepreneurs and external
partners (that may not even be in your
industry) bring to the equation? Learn
how to identify, inspire and grow the
new class of innovators to transform
your work or business.
|
|
